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The standard peritoneal permeability analysis: A tool for the assess-
ment of peritoneal permeability characteristics in CAPD patients. Pen-
toneal transport characteristics in CAPD patients are often assessed by the
peritoneal equilibration test (PET), which uses a four hour dwell with
glucose 2.27% dialysate. From the test, the dialysate/plasma ratio of
creatinine (D/Pr), the dialysate/initial dialysate ratio of glucose (DID0)
and net ultrafiltration (NUF, drained minus instilled volume) are calcu-
lated. The standard penitoneal permeability analysis (SPA) is a modifica-
tion and extension of the PET: glucose 1.36% dialysate is used, to which
dextran 70 (1 g/liter) is added for the calculation of fluid kinetics. Mass
transfer area coefficients (MTAC's) of low molecular weight solutes,
clearances of proteins and the change in intrapenitoneal volume (zIPV)
can be assessed. In this study the SPA was analyzed, and a comparison
with the PET was made. A total number of 138 SPA's was analyzed in 86
different clinically stable patients. Normal values were calculated for both
SPA and PET parameters in the same tests. Median (ranges) of compa-
rable transport parameters from SPA and PET were: MTACCr, 10.4
mllmin (5.7 to 19.3); glucose absorption, 61% (35 to 87); IPV, 9.5 ml
(—761 to 310); D/Pr, 0.76 (0.53 to 1.14); D/D0, 0.37(0.13 to 0.56); NUF,
—75 ml (—675 to 450). The agreement between SPA and PET was
analyzed using the method of Bland and Altman. A fairly good agreement
was present between NUF and IPV. Systematic errors were found when
D/Pcr and MTACC. were compared: D/P overestimated MTAC mainly in
the low range, whereas in the high range values were underestimated. A
similar pattern was seen for the transport parameters of glucose. In 40
patients negative net ultrafiltration was present, and possible reasons for
this were assessed. In 9 patients no reason could be identified. It can be
concluded that the SPA provides useful and extensive information on
peritoneal transport parameters. Compared to the PET, the SPA has
better discriminative power for the transport of glucose and creatinine.
Measurement of the transport properties of the peritoneal
membrane is used in individual patients treated with peritoneal
dialysis for both the characterization of the functional state of this
biological membrane and the assessment of the required dialysis
dose. Such measurements are useful because patients show dis-
tinct intra- and intenindividual variabilities [1—41. Moreover, the
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continuous exposure to dialysis fluids may lead to functional
alterations in the membrane [5—11]. The peritoneal equilibration
test (PET) is currently the most widely used test to assess
peritoneal transport in CAPD patients [12]. The principle of such
a test was proposed by several authors [13—16], but standardized
to its present form by Twardowski et al in 1987 [12]. The PET is
performed during a four hours dwell using glucose 2.27% dialy-
sate. It measures low molecular weight solute transfer and net
ultrafiltration. The dialysate/plasma ratio of creatinine (DIPr)at
the end of the procedure, and the dialysate240/initial dialysate
ratio of glucose (DID0) are calculated and used as parameters of
solute transport. Net ultrafiltration (NUF) is calculated as the
difference between the drained and the instilled volume. Patients
are categorized into low, low-average, high-average and high
transporters according to the values of solute transport. A high
transporter is defined as a patient with either a D/Pr exceeding
the mean + I SD, or a D/D0 of less than the mean DID0 — I SD.
High average transporters have a D/Pr between the mean and
mean + I SD, or a D/D0 between the mean and mean —1 SD.
Analogously, the other two groups are defined. Recommenda-
tions have been made on the mode and quantity of peritoneal
dialysis according to the transport status of the patients [17, 181.
One of the major reasons for the wide-spread use of the PET is
the standardization of the procedure and the simplicity of its
calculations [7, 17, 18]. The PET is based on the assumption that
peritoneal transport is diffusive. However, especially when hyper-
tonic dialysis fluids are used DIPr is also influenced by convective
transport from the circulation to the peritoneal cavity [19].
Likewise DID0 is not only dependent on diffusion, but also on
uptake into the lymphatic system. Furthermore, net ultrafiltration
is determined by transcapillary ultrafiltration, and by lymphatic
drainage of the peritoneal cavity.
The standard penitoneal permeability analysis (SPA), as devel-
oped in our unit, is a modification and extension of the PET.
Several differences exist: the SPA is performed using glucose
1.36% dialysate, preceded by rinsing of the peritoneal cavity.
Dextran 70 is added to the test solution for the measurement of
fluid kinetics and residual volume [20]. The transport of low
molecular weight solutes is expressed as the mass transfer area
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coefficient (MTAC) of urea, creatinine and urate. The glucose
absorption is calculated relative to the amount instilled. In
addition, peritoneal clearances of 132-microglobulin, albumin, IgG
and a2-macroglobulin are assessed. These values are used to
calculate the peritoneal restriction coefficient, which can be
regarded as a parameter for the intrinsic permeability of the
peritoneum to macromolecules (see Methods section) [1]. The
parameters obtained in the PET can easily be used to calculate the
MTAC of low molecular weight solutes and the absorption of
glucose. Conversely, the determinations done in the SPA can also
be expressed as D/Pcr and DID0 glucose.
The aims of the present study were first to analyze the SPA in
a large group of patients to define normal ranges, and subse-
quently, we compared the data on the transport of low molecular
weight solutes obtained with the values of DIPCr and D/D0 in the
same tests in each individual patient. The agreement of the two
methods for the characterization of peritoneal transport and the
consequences for clinical practice were assessed. Finally, the
patients with negative net ultrafiltration were identified and
analyzed, with regard to the potential causes.
Patients
A total number of 138 standard peritoneal permeability analy-
ses (SPA) was performed in 86 clinically stable CAPD patients
with a median age of 51 years, range 21 to 80 years. The median
duration of CAPD treatment was 2.1 years, range 0.33 to 13.5
years. SPA's are performed in all patients in our peritoneal
dialysis unit on a yearly and voluntary basis. The tests are repeated
more frequently when clinical problems occur. All analyzed SPA's
were done between November 1990 and April 1994. Forty-five
patients were studied once. In 30 patients two, and in ii patients
three or more tests were done for various reasons. All patients
used commercially available, glucose based dialysate (DianeaF1;
Baxter BY, Utrecht, The Netherlands). At the time of the test, 42
patients used 1.5 liter exchanges, 92 used 2 liters and 4 patients 2.5
liters of dialysate. None of the patients had peritonitis during the
test or four weeks prior to the SPA.
Procedure of the SPA
The SPA is performed in an outpatient setting. The patient sits
in a comfortable armchair during the test. All tests are performed
during a four hours dwell with Dianeal> 1.36% dialysate using the
volume the patient is accustomed to. To all test bags dextran 70,
I glliter (Macrodex; NPBI, Emmercompascuum, The Nether-
lands) is added to calculate peritoneal fluid kinetics [20, 211. Prior
to instillation of the test solution the peritoneal cavity is rinsed
with Dianeal® 1.36% and immediately drained by gravity after
inflow is completed. Dialysate samples from the test bag of 10 ml
each are collected before inflow and at 10, 20, 30, 60, 120, 180 and
240 minutes after instillation of the test solution. To avoid a
dead-space effect, 100 to 200 ml is temporarily drained before the
collection of each sample. After drainage at 240 minutes the
peritoneal cavity is rinsed with Dianeal® 1.36% again, similar to
the start of the procedure. Samples from this bag are used to
calculate the residual volume. Blood samples are taken at the start
and at the end of the test. Dextran 1, Promiten® (NPBI), 20 ml is
given intravenously after the first blood sample is drawn, to
prevent possible anaphylaxis to dextran 70 [22].
Solute transport
(1)
Assays
Total dextran was determined by means of high performance
liquid chromatography [231. For urea the DAM-TCS Technicon
SD4 to 001 DK1 method was used. Creatinine was measured by
either the modified Jaffe method or with an enzymatic method
(Hitachi H747, Boehringer Mannheim, Germany). For glucose a
glucose oxidase-peroxidase method was used. All were deter-
mined on autoanalyzers (SMA and SMA-Il; Technicon Corp.,
Terrytown, NJ, USA). Creatinine concentrations were corrected
for the glucose concentration in the dialysate, when measured
according to Jaffe. Beta-2-microglobulin was determined with a
microparticle enzyme immunoassay with an IMx system (Abbott
Diagnostics, North Chicago, IL, USA). Albumin, IgG and a-2-
macroglobulin were all measured by nephelometry (BN100;
Behring, Marburg, Germany), with commercial antisera (Dako-
patts, Glostrupp, Denmark).
Calculations in the SPA
Each experiment was analyzed individually for the determina-
tion of solute transport of low molecular weight solutes and
macromolecules, for the restriction coefficient and for fluid kinet-
ics.
Solutes are transported from the peritoneal capillaries into the
peritoneal cavity by both diffusion and convective transport. The
difference between blood and dialysate concentrations deter-
mined the diffusion of a solute. Convective transport was depen-
dent on the transcapillary ultrafiltration rate, the sieving coeffi-
cient (the concentration ratio of a solute in the ultrafiltrate and in
the plasma) and on the concentration in the membrane. For the
transport of low molecular weight solutes a clearance cannot be
used, because after a dwell of four hours a near equilibrium
situation is often present. Therefore, the transport of low molec-
ular weight solutes is expressed as the mass transfer area coeffi-
cient (MTAC). This is the maximal theoretical clearance of a
solute by diffusion at t = 0, and thus before diffusion has actually
started. The MTAC was calculated for urea, urate and creatinine.
Two models were used: a modification [3] of the Garred et al
model [24] and the model according to Waniewski et at [25]. The
two methods differ in the value which is attributed to F. This is a
weighing factor, which estimates the relative importance of con-
vective transport in comparison to diffusive transport [25]. A value
of F = 0, as applied by Garred et at, means that convective
transport is more important than diffusion. This is not the case
during peritoneal dialysis, as has been shown previously [261.
Therefore, in the model proposed by Waniewski et a! [25], a value
of F = 0.5 was applied. In the Garred model MTAC was
calculated using the equation:
Vd VPMTAC (mi/mm) —. In
Vd (P - D,
in which Vd is the volume of the drained bag, and V1 the instilled
volume. D represents the dialysate concentrations of the solute
after 240 minutes, and P the mean plasma concentration of this
solute. The Waniewski model corrects for convective transport
more appropriately, with the application of a correction factor
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F = 0.5 [25, 27], as well as for plasma water [27]. The model uses
the following equation:
v v0- F (P — D10)MTAC (mi/mm) = — in v -F (P — D)
in which V10 represents the intraperitoneal volume, and D10 the
dialysate concentration at t = 10 minutes, whereas Vt and D are
these parameters at time t = 240 minutes. Vm is the mean
intraperitoneal volume, calculated as the area under the intraper-
itoneal volume versus time curve, divided by the dwell time. This
area was calculated by the trapezium rule [28]. Using this method
the area under the curve between two dialysate samples is
calculated as the mean of the intraperitoneal volume at the two
sample times, multiplied with the time interval between the
samples.
Glucose absorption was calculated as the difference between
the amount of glucose instilled and the amount recovered, relative
to the amount instilled.
Protein clearances were calculated from the amount of protein
in the effluent according to:
PrDr + PrRVCl (mi/mm) = __________(Pr)t
In this equation the dialysate protein content in the drained test
bag (PrDr) and in the residual volume (PrRV) relative to the
plasma protein concentration (Pro) in time (t) is calculated. A
clearance can be used for the transport of macromolecules
because the diffusion of these solutes is so slow that their
concentration in the dialysate after four hours can be neglected.
The intrinsic permeability to macromolecules can be functionally
characterized by the peritoneal restriction coefficient (rc). This is
the slope of the power relationship between the clearance of
serum proteins and their free diffusion coefficient in water (Dw)
[1, 29, 30]:
Clearance = a DWrC
Fluid kinetics
Fluid is transported from the peritoneal capillaries into the
peritoneal cavity and transported back by uptake into the lym-
phatic system and by backfiltration. Therefore, the net changes in
intraperitoneal volume are the result of transcapillary ultrafiltra-
tion and lymphatic absorption. Both parameters can be assessed
with an intraperitoneally administered volume marker like dextan
70. The convective loss of dextran during the dwell was used to
calculate the effective lymphatic absorption (ELAR). This implies
that all pathways of lymphatic drainage from the peritoneal cavity,
both subdiaphragmatic and interstitial, are included in the defi-
nition of the ELAR. It is calculated from the dextran disappear-
ance rate:
(Dx1 — DXr)ELAR (mi/mm) = ________
(DXgeom)t
in which the difference between the instilled (i) and recovered (r)
dextran mass is divided by the geometric mean of the dialysate
dextran concentrations [29]. The change in intraperitoneal vol-
ume (IPV) during the dwell can be calculated from the dilution
of dextran after correction for incomplete recovery. This param-
(2)
eter is comparable to the net ultrafiltration in the PET. The
transcapillary ultrafiltration at any time point (TCUF) is calcu-
lated from the theoretical intraperitoneal volume at that time
(when both lymphatic absorption and the sampling would not
have been present), minus the initial IPV. Likewise, the net
ultrafiltration rate (NUFR) is calculated, by dividing the
L\JPV24Q by the dwell time [29]. The residual volume (RV) is
determined by the following equation, in which rs is rinsing
solution, ts is test solution, V is volume, and C is concentration
[31]:
(V•C)RV(ml) =
—
(6)
A first analysis revealed a correlation with body surface area
(BSA) for both MTACCr (r = 0.17, P = 0.05) and ELAR (r =
—0.25, P = 0.003). Therefore, transport parameters of the SPA
were corrected for BSA, where appropriate.
Statistical analysis
Results are expressed as mean SD for data with a normal
distribution. Median values and ranges are given for asymmetri-
(3\ cally distributed data. For the definition of the normal ranges ofthe parameters, only the most recent SPA of every patient was
included in the calculations (N = 86). This avoids an excessive
contribution of values obtained shortly after the initiation of
CAPD.
For the comparison of SPA with PET, all data were used (N =
138). The PET categorization was performed as usual [121. The
patients were categorized in the SPA, analogous to the method
described above for the PET categorization, after the data had
been adjusted for skewed distribution. In unimodel skew distri-
butions, like most data obtained from the SPA, the moment of
skewness is measured by calculating the coefficients of skewness
[32]. We calculated these for our data. Subsequently the data were
identified that would be required for a normal distribution (that is,
(4\ coefficient of skewness is zero). For positively skewed distribu-
tions (tail to the right, coefficient of skewness >0), data with the
highest values were omitted one by one, until that set of data were
found with a coefficient of skewness closest approaching zero. In
this way, data exceeding the upper level of normal distribution
(outliers) could be identified and a categorization of the data in
analogy of the PET (mean 1 SD) could be performed.
The Spearman rank correlation test was used to assess the
correlations between the SPA and the PET results. In addition,
both tests were compared using the method introduced by Bland
and Altman [33, 34J. In this type of analysis the difference between
individual values of SPA and PET were plotted against their
means. As MTAC's were expressed in mi/mm and DIP ratio's had
no dimension; all 138 values were expressed as percentages of
their mean.
The outliers of MTAC, ELAR, and residual volume were
determined using the method as mentioned above for not nor-
(5) mally distributed data, and used for the identification of data out
of the normal range in the tests with negative net ultrafiltration.
Results
Nomial values
Normal values for the transport parameters of low-molecular
weight solutes in 86 different patients, for both SPA and PET, are
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Table 1. Normal values for the transport of low molecular weight solutes from standard peritoneal permeability analyses (SPA) and PET results of
the same tests in 86 clinically-stable CAPD patients
Parameter Median Total range
Mean of normal
distribution
95% Confidence
interval N
Standard permeability analysis
According to simplified Garred model
MTACura
MTACC
MTACurate
According to Waniewski model
MTACura
MTACCr
MTACurate
Gluc.abs.
16.4
9.9
8.2
17.6
10.9
8.9
61
9.5—26.3
5.6—17.9
4.0—22.1
9.5—26.3
5.7—19.3
4.4—23.8
35—87
16.0
9.4
7.9
17.5
10.2
8.6
61
10.7—21.2
5.5—13.4
3.9—11.8
11.5—23.5
5.7—14.7
4.1—13.0
35—87
81
74
85
83
74
76
85
Peritoneal equilibraiton test
D/Pcr
DID0
0.79
0.36
0.52—1.14
0.13—0.56
0.77
0.37
0.59—0.95
0.20—0.53
85
85
N is the number of patients used for the calculation of the 95% confidence interval after omitting the outliers (see text).
Abbreviations are: D/DO, initial dialysate glucose concentration/glucose concentration at t =240 mm; D/Pcr, dialysate/plasma ratio of creatinine at
= 240 mm; Gluc.abs., glucose absorption (%); MTAC, mass transfer area coefficient (ml/min/1.73 m2).
Table 2. Normal values for the transport of macromolecules from 86 standard peritoneal permeability analyses
Mean of normal 95% Confidence
Parameter Median Total range distribution interval N
C1132m 851 341—2414 853 400—1310
ClaIb 92 10—260 89 34—144
80
78
ClIgG 47 10—148 45 15—76 79
Clazm 15 3—67 13 3—23
rc 2.32 1.89—3.22 2.26 1.92—2.59
68
70
N is the number of patients used for the calculation of the 95% confidence interval after omitting the outliers (see text).
Abbreviations are: a2m, alpha-2 macroglobulin; alb, albumin; J32m, beta-2 microglobulin; Cl, clearance (d/min/1.73 m2); rc, restriction.
Table 3. Normal values for fluid transport from 86 standard peritoneal permeability analyses
Mean of normal 95% Confidence
Parameter Median Total range distribution interval N
Standard permeability analysis
Mean TCUFR 1.1 0.1—3.0 1.05 0.30—1.80 79
ELAR 0.95 0.36—3.9 0.75 0.40—1.16 51
Mean NUFR 0.07 —2.5—+1.5 0.1 —0.8—+1.1 78
IPV 230 —761—+310 30 —201—+360 78
RV 230 44—706 203 34—372 75
Peritoneal equilibration test
Net UF —85 —675—+450 —84 —454--+286 83
N is the number of patients used for the calculation of the 95% confidence interval after omitting the outliers (see text).
Abbreviations are: IPV, change in intraperitoneal volume (ml); ELAR, effective lymphatic absorption rate (ml/min/1.73 m2); NUFR, net
ultrafiltraiton rate (ml/min/1.73 m2); RV, residual volume (ml); TCUFR, transcapillary ultrafiltration rate (ml/min/1.73 m2); UF, ultrafiltration (ml).
shown in Table 1. The transport parameters of macromolecules
and those for fluid kinetics are given in Tables 2 and 3.
SPA versus PET
The comparison of the 138 PET and SPA results revealed
strong correlations between D/Pr and MTACCI (both methods,
r  0.85, P < 0.00001), between DID0 and glucose absorption (r =
—0.91, P < 0.00001), and between net ultrafiltration and iIPV
(r = 0.68, P < 0.00001), as shown in Figure 1. Net ultrafiltration
and MPV are compared using the Bland and Altman plots in
Figure 2. The random distribution that was present when the
differences between the two parameters were plotted against their
means implied that no systematic errors relative to the magnitude
of ultrafiltration were present. However, the mean difference
between net ultrafiltration and LIPV was slightly negative, prob-
ably because the residual volume is taken into account only in
LJPV. The comparison of the simplified Garred model and the
Waniewski model for MTACC. showed no indication for a
systematic error relative to the absolute value either (Fig. 3). Note
that the mean value for MTACCr was somewhat higher using the
Waniewski model.
The pattern that was observed for the comparison between
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Fig. 1. Correlations between SPA and PET parameters in 138 tests perfbrmed in 86 stable CAPD patients. (A) MTACCr versus DIPCr (N = 138; r = 0.85;
P < 0.0001). (B) Glucose absorption versus DID0 glucose (N = 138; r = —0.91; P < 0.00001). (C) IPV versus net ultrafiltration (N = 138; r = 0.68;
P < 0.00001. Correlation coefficients are based on linear regression analysis.
Fig. 2. Analysis of the agreement between JPV
(SPA) and net ultrafiltration (PET), as assessed by
the method of Bland and Altman. No systematic
errors are made relative to the magnitude of
ultrafiltration. Mean net ultrafiltration is exceeded
by zdPV because the residual volume is taken
into account only in the calculations of the latter.
MTACCr and DIPcr is shown in Figure 4. It is evident that no
random distribution was present. On the contrary, strong corre-
lations were found between the differences and means of the
transport parameters of creatinine. The correlation coefficients of
these relationships were r = —0.83 and —0.82 (P < 0.00001 for
both). This implies that systematic errors were present relative to
the magnitude of the transport parameters. These errors mainly
occurred in the extreme ranges. Between 90 and 110% of the
mean values the two methods agreed fairly well, but in the low and
high ranges differences were more pronounced (Fig. 4). A similar
pattern was observed for the comparison between DID0 glucose
and the glucose absorption, as is shown in Figure 5.
We further addressed the consequences of these systematic
errors for clinical practice. In Table 4 the categorization in
transport groups is shown for the transport parameters of creat-
mine and glucose. It is clear that some patients were placed in
different transport categories, based on whether the SPA or the
PET was used for the calculations. This phenomenon was most
evident for creatinine (59 out of 138 tests would have led to
misplacement), but although to a lesser extent, it was also present
for glucose (31 out of 1138 tests).
Analysis of patients with negative ultrafiltration in the SPA
Forty patients of the 86 patients had negative net ultrafiltration
(IPV < 0 ml) during the SPA with glucose 1.36% dialysate. The
possible reasons for this lack of ultrafiltration, such as a large
effective peritoneal surface area (high MTACCI), a small effective
peritoneal surface area (low MTACCr), a high ELAR, a large
residual volume (RV), or a combination of them, were analyzed in
these patients. Values were considered abnormal when they
exceeded the 95% confidence interval given in Table 1. The
Waniewski model was used for the calculation of MTACCr. Table
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5 shows the results of this analysis. In 31 patients one or more
possible explanations for the negative ultrafiltration were found.
No reason for the lack of net ultrafiltration could be identified in
the other 9 patients (23%).
Discussion
In the present transversal study normal values were obtained in
a large group of stable CAPD patients for the mass transfer area
coefficients of low-molecular weight solutes, clearances of serum
proteins, and the kinetics of fluid transport, measured during a
standard peritoneal permeability analysis (SPA). The SPA can be
regarded as a modification of the commonly used PET; the main
differences are the use of glucose 1.36% dialysate and the
administration of dextran 70 for the measurement of fluid kinet-
ics.
The transport capacity of the peritoneum for solutes and fluid,
in its function as a dialysis membrane, is dependent on its surface
area. The anatomic (mesothelial) surface area bears some rela-
tionship to body surface area [35, 36]. The functional or effective
peritoneal surface area is probably mainly determined by the
number of perfused capillaries. This may be the explanation for
the weak, but significant correlations that were found between the
transport parameters and body surface area. The practical conse-
quence is that the parameters of peritoneal transport should be
expressed per 1.73 m2.
The normal values for the SPA found in this study are based on
single tests in 86 different patients. Even when the outliers were
omitted, the 95% confidence interval of most parameters was very
wide, implying large interindividual variability. No differences
existed between the MTAC's of low-molecular weight solutes,
calculated according to the two different models used in the
present study. This could be expected because convective trans-
port was limited as much as possible by the use of glucose 1.36%
dialysate. The transport of low molecular weight solutes showed
the highest MTAC for urea, followed by creatinine and urate, as
expected based on their increasing molecular weight. Similarly,
the clearances of macromolecules were lower the higher their
molecular weight.
The values obtained in this study are similar to those reported
in previous studies performed by our group [11, 29, 37, 38], except
for the ELAR. The 95% confidence interval of ELAR was 0.40 to
1.16 ml/min/1.73 m2, whereas mean values ranging from 1.03 to
1.37 ml/min have been reported in previous studies in our group
using dextran 70 as a volume marker [20, 21, 29, 37, 38]. However,
the median value in the present study was similar to that of 1.0
mi/mm found in an analysis of the first 30 patients [23]. The large
inter- and intra-individual variability is the most probable cause
for these differences. The magnitude of the interindividual varia-
tion is illustrated by the total range that was 0.36 to 3.9 mI/min/
1.73 m2 in the present study. The presence of outliers with very
high ELARs could have influenced our previous studies that were
done in a smaller number of patients. An intraindividual coeffi-
cient of variation for ELAR of 23% was found in the study of
Imholz [39]. In that study six SPA's were performed within a
period of two weeks in eight stable CAPD patients. The influence
of posture on transport parameters was also adressed in that
study. It showed that net ultrafiltration is higher in the supine than
in the upright position, which is caused by a combination of a
slightly higher TCUFR and lower ELAR [39]. The SPA is not
performed in a recumbent position, because this is less comfort-
able for the patients. Furthermore, the test does not aim to
measure maximal values. Because of the influence of posture,
however, the test should always be performed in a standardized
way.
The ELARs we found in the present study are markedly lower
than the mean values obtained with autologous hemoglobin (1.59
mI/mm) [40], and human serum albumin (1.49 mi/mm and 1.52
ml/min) [41, 42]. For radio-iodated serum albumin mean values of
1.9 mllmin [43] and 1.7 mllmin [19] have been reported for 3.86%
glucose dialysate, and of 1.2 mi/mm for 1.36% and 2.27% glucose
dialysate [19]. It is speculative whether the lower values obtained
with dextran 70 are only the result of the small series using the
other markers, or whether the other markers give some overesti-
mation of the effective lymphatic absorption rate. The PET has
been advocated both for the characterization of the peritoneal
membrane for solute transport, and for the prediction of weekly
creatinine and urea clearances to determine the adequacy of
dialysis [12, 17, 18]. Furthermore, recommendations for the mode
of dialysis treatment have been made according to a division in
four transport groups [12, 17, 18, 44]. The measurement of
adequacy of peritoneal dialysis by means of the PET has been
questioned in several studies [17, 45, 46]. Davies et al described
the PET as a useful adjunct to peritoneal dialysis prescription, but
limit the use of this test to repeated measurements in one patient
[17]. Other studies reported both over- and underestimation of
24-hour creatinine clearances by the PET [45, 46]. Problems occur
when extrapolation of four hour DIP ratios to 24-hour clearances
are performed [45, 46]. Also, differences in over- or underestima-
tion exist in the different transport groups, and in the influence of
the use of different solutions for the test [46]. As in the PET,
extrapolation of data from the SPA to 24 hour clearances is
difficult and should be avoided. The only way to perform acurate
prescription of dialysis treatment is based on 24-hour dialysate
and urine collections. The SPA can, however, be useful in finding
possible causes of ultrafiltration problems, as shown in the present
study.
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4 tive transport in a test with 3.86% glucose dialysate, when
• compared to 2.27% or 1.36% glucose containing dialysate [7, 26].
Another drawback of the use of DIP ratio is that the dialysateE 3 • volume is not taken into account, This may especially be relevant
comparisons are made between dialyses with different
c' 2 • : dialysate volumes. In a comparison between 2 liter and 3 liter
• • dialysate the MTAC values were not different [48]. The D/P ratio
= . s.• • • • of creatinine in this group of patients was similar, but for urea
s 1 .• •, • • differences were present between the 2 and the 3 liter exchanges.
•. z: •: '.. • Furthermore, unexplained differences in PET results between
0 s s • • different patient populations have been reported [17, 49], despite•
• •' • • its good reproducibility [12, 50].
• The normal values of the PET parameters, as calculated from
—1
____________________________________________
our SPA results were similar to those in the study of Twardowski,
Khanna and Nolph [44]. A small difference was seen in the mean
D/Pcr between both studies, but the 95% confidence interval
showed complete overlap.
In the comparison of both methods, the strong correlations
present between the SPA and PET parameters, as assessed by
linear regression correlation analysis, give an unrealistic image of
the true agreement of SPA and PET. This occurs because
correlation analysis is an inappropriate tool to determine the
agreement between two methods, which aim to measure the same
entity. It still is often used, however, for such purposes [7, 17, 18,
With regard to the functional state of the peritoneal membrane, 44, 50]. In our comparison of SPA and PET parameters, using the
the question remains of whether the PET can provide accurate method of Bland and Altman [33, 34], we found a fairly good
information on peritoneal permeability characteristics. This issue agreement of LIPV (SPA) and net UF (PET). No systematic
was addressed in the present study, along with the ability of the errors were made, although the large 95% confidence interval
PET to categorize patients into transport groups, based on its indicates that differences between zIPV and net UF can be
results. In theory, functional characterization of the peritoneum is extensive due to the changes in residual volume. Also, the two
difficult using the PET because it is performed with 2.27% glucose models used for the calculation of MTACCr did not show system-
based dialysate, which is likely to induce more convective trans- atic errors. The agreement between the two methods implies that
port than glucose 1.36%. However, conflicting reports have been both the simplified Garred model and the Waniewski model can
published about this subject. In one study no differences were be used for the calculation of MTACs of low-molecular weight
found for D/PC. between 1.36% and 3.86% glucose containing solutes in a test. This confirms previous observations of our group
dialysate [471, but others reported a clear contribution of convec- in 10 patients [29]. As the Waniewski model uses a volume
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Table 4. Comparison of transport categories for SPA and PET results from all 138 tests
MTACr mi/min/1.73 m2 Glucose absorption %
Low LA HA High Total Low LA HA High Total
DIPcr DID0
Low 12 6 1 0 19 Low 15 6 0 0 21
LA 10 18 18 0 46 LA 2 38 11 0 51
HA 0 7 23 17 47 HA 0 1 44 7 52
High 0 1 0 25 26 High 0 0 4 10 14
Total 22 32 42 42 138 Total 17 45 59 17 138
The transport categorization of creatinine is shown in the left part of the table, the transport categorization of glucose in the right part. The bold
numbers show corresponding transport groups for both tests. See Table I for abbreviations.
Table 5. Possible reasons for negative ultrafiltration in a SPA using
1.36% glucose based diaiysate in 40 CAPD patients
Reason for
negative net UF
Number of
patients Median Range
High MTACC, 12 14.8 13.8 —19.2
Low MTACCr 0 — —
ELAR 24 1.8 1.3—3.9
RV 5 452 378—633
No reason found 9 — —
Total 50
a In 8 patients a combination of 2, and in one of 3 possible causes was
present.
Normal limits are based on mean 2 SD after omitting the outliers
(Tables 1 and 3). See Table 1 for normal ranges and abbreviations.
marker, while the simplified Garred model uses only plasma
values, dialysate values after drainage and the drained volume, it
implies that the simplified Garred model can be used for the
calculation of the MTACCr in clinical practice.
In contrast to the comparison of the two MTAC models, the
pattern of the relationship between the differences and the means
of the transport parameters of creatinine was very different.
Systematic errors relative to the magnitude of transport were
clearly present. These errors cannot be attributed solely to
convective transport, because errors were similar for both the
Waniewski model and the simplified Garred model. It implies that
DIP ratios cannot be used as a simple estimation of the MTAC.
The same holds true for DID0 glucose and glucose absorption.
Comparing DIP ratios with MTACs one could argue about the
problem of the gold standard. We think that the MTAC should be
considered the reference method because: (1) it is the theoretical
maximum diffusional clearance at time zero, so not influenced by
saturation of the dialysate during the dwell; (2) it is not dependent
on the tonicity of the dialysate [29]; (3) it is not influenced by the
dialysate volume in the range between 2 and 3 liters [26]; and (4)
it has a better discriminative power, especially in the extreme
ranges, as shown in the present study. The latter may be of
importance for clinical practice, since this could result in earlier
discovery of changes in peritoneal function.
According to some authors, advice for dialysis treatment can be
given based on the PET categorization in transport groups [12, 17,
18, 50]. Our study has shown that in a large number of tests the
patient is placed into a different transport category, based on
either SPA or PET results. This implies that these patients would
receive different advice for their dialysis treatment. It again
illustrates that tests of short duration have only a limited value in
the choice of the most adequate dialysis scheme. For estimation of
the adequacy of any prescribed dialysis dose, 24-hour dialysate
and urine collections are essential to measure the appearance
rates of urea and creatinine in relation to the plasma concentra-
tions [51].
Using the results of the SPA, the possible causes for ultrafil-
tration failure can be established, as was done in the patients with
a negative net ultrafiltration. The most frequent reason for lack of
ultrafiltration is a large effective peritoneal surface area, leading
to a rapid disappearance of glucose [8, 9]. In addition a high
effective lymphatic absorption rate has been described as a
possible cause [43, 52, 531. Also, a large residual volume leads to
an immediate dilution of the solution and thus to an instant
decrease of the osmotic gradient. One or more possible causes
could be identified in most patients in the present analysis. The
large number attributed to a high ELAR is probably caused by the
relatively low mean value for ELAR we found in the present
study. The upper limit of the 95% confidence interval of the
normally distributed data were 1.16 ml/minll.73 m2. When we set
an arbitrary limit to ELAR of 2 ml/min/1.73 m2, a value exceeding
this limit was found in only nine patients.
None of the reasons for ultrafiltration failure mentioned above
could be identified in 23% of the patients with negative ultrafil-
tration. It has been made likely that a part of the transcapillary
transport of water, induced by an osmotic gradient, takes place
through ultrasmall pores [54]. This may be the explanation for the
sieving of sodium that occurs during dialysis using 3.86% glucose
dialysate [19, 55]. In a recent study in six other CAPD patients
with very severe unexplained net ultrafiltration failure, who were
studied with 3.86% glucose dialysate, we found no sieving of
sodium, and interpreted this finding as possible impairment of
transcellular water transport [56]. It remains speculative whether
such impaired transcellular water transport was also the cause of
net ultrafiltration failure in the patients of the present study,
because they were only studied with glucose 1.36% containing
dialysate.
In conclusion, the SPA provides useful and extensive informa-
tion on transport parameters of the peritoneal membrane in
peritoneal dialysis patients. When compared to the PET, the SPA
has better discriminative power for both the transport of creati-
nine and glucose. The results obtained with the classical PET
procedure should be used to calculate the MTACCI and the
absorption of glucose. More information can be obtained when a
volume marker is administered intraperitoneally. In patients with
unexplained net ultrafiltration failure a SPA using 3.86% glucose-
containing dialysate should probably be added to the investiga-
tion.
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